Disconnect Between Recurrence-Free Survival and Overall Survival for Newly Diagnosed Glioblastoma Patients Receiving Adjuvant Bevacizumab

被引：0
|
作者：
Arvold, N. D. [1 ]
Wen, P. Y. [1 ]
Reardon, D. A. [1 ]
Lee, E. Q. [1 ]
Pinnell, N. E. [1 ]
Christianson, L. W. [1 ]
Weiss, S. E. [2 ]
Dunn, I. F. [1 ]
Ligon, K. L. [1 ]
Alexander, B. M. [1 ]
机构：
[1] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA
[2] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2013年 / 87卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2013.06.049
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S17 / S17
页数：1
相关论文
共 50 条
  • [41] Conditional Probability of Survival in Patients With Newly Diagnosed Glioblastoma
    Polley, Mei-Yin C.
    Lamborn, Kathleen R.
    Chang, Susan M.
    Butowski, Nicholas
    Clarke, Jennifer L.
    Prados, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (31) : 4175 - 4180
  • [42] THE CONDITIONAL PROBABILITY OF SURVIVAL IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS
    Polley, Mei-Yin C.
    Lamborn, Kathleen R.
    Chang, Susan M.
    Butowski, Nicholas
    Clarke, Jennifer L.
    Prados, Michael
    NEURO-ONCOLOGY, 2010, 12 : 55 - 55
  • [43] Everolimus shortens survival of newly diagnosed glioblastoma patients
    Wong, Eric T.
    Swanson, Kenneth D.
    JOURNAL OF NEURO-ONCOLOGY, 2018, 140 (01) : 179 - 180
  • [44] Radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of overall survival and recurrence-free survival
    Gardini, Andrea Casadei
    Marisi, Giorgia
    Canale, Matteo
    Foschi, Francesco Giuseppe
    Donati, Gabriele
    Ercolani, Giorgio
    Valgiusti, Martina
    Passardi, Alessandro
    Frassineti, Giovanni Luca
    Scarpi, Emanuela
    ONCOTARGETS AND THERAPY, 2018, 11 : 6555 - 6567
  • [45] Overall Survival in Patients with Glioblastoma Before and After Bevacizumab Approval
    Johnson, Derek R.
    Omuro, Antonio M. P.
    Ravelo, Arliene
    Sommer, Nicolas
    Guerin, Annie G.
    Ionescu-Ittu, Raluca
    Shi, Sherry
    Uhm, Joon H.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 363 - 363
  • [46] Overall survival in patients with glioblastoma before and after bevacizumab approval
    Johnson, Derek R.
    Omuro, Antonio M. P.
    Ravelo, Arliene
    Sommer, Nicolas
    Guerin, Annie
    Ionescu-Ittu, Raluca
    Shi, Sherry
    Macalalad, Alex
    Uhm, Joon H.
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (05) : 813 - 820
  • [47] Comment on: Correlation between recurrence-free survival and overall survival after upfront surgery for resected colorectal liver metastases
    Li, Jin
    Zhang, Zitong
    Chu, Bingyang
    BRITISH JOURNAL OF SURGERY, 2023, 110 (11) : 1558 - 1558
  • [48] Prognostic Factors for Progression-free Survival and Overall Survival Αfter Recurrence of Glioblastoma
    Zemskova, Oksana
    Yu, Nathan y.
    Leppert, Jan
    Rades, Dirk
    ANTICANCER RESEARCH, 2024, 44 (07) : 3059 - 3066
  • [49] Net survival in recurrence-free colon cancer patients
    Drouillard, Antoine
    Bouvier, Anne-Marie
    Boussari, Olayide
    Romain, Gaelle
    Manfredi, Sylvain
    Lepage, Come
    Faivre, Jean
    Jooste, Valerie
    CANCER EPIDEMIOLOGY, 2019, 61 : 124 - 128
  • [50] INCREASING TTFIELDS DOSE TO THE TUMOR BED IMPROVES OVERALL SURVIVAL IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS
    Ballo, M.
    Bomzon, Z.
    Urman, N.
    Lavy-Shahaf, G.
    Toms, S. A.
    NEURO-ONCOLOGY, 2018, 20 : 257 - 257
12345